ERBB2 and neoplasm: Intratumoral injection of P/PB/N/R nanoparticles generates anti-HER2 CAR-Ms by the engineering of TAMs and causes phagocyte of tumor cells, enhances the innate and adaptive immune system response, and tumor regression in mice without any notable side effects [121].